第60回日本神経学会学術大会

セッション情報

印刷

East Asian Neurology Forum

[EANF-01] GBS in Asia

2019年5月24日(金) 08:00 〜 09:30 第6会場 (大阪国際会議場10F 会議室1009)

座長：Bart Jacobs（Departments of Neurology and Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands）, 桑原 基（近畿大学医学部神経内科）

There are regional variations in the clinical features of Guillain-Barré syndrome (GBS). Acute motor axonal neuropathy (AMAN) and Miller Fisher syndrome are more frequently seen in the east Asia including Japan than in the western countries. In particular, AMAN type is reported to be far more frequent in Bangladesh than in the other regions. Expensive thrapies such as IVIg and plasmapheresis are not always available in the developing countries. In this symposium, clinical features and therapies of GBS in several Asian countries ( Korea, China and Bangladesh) will be reported. Such information should be useful for Japanese neurologists.

[EANF-01-1] The Clinical Variety of Korean Guillain-Barré Syndrome

Jong Kuk Kim1,2, Byeol-a Yoon1,2, Jong Seok Bae3 (1.Department of Neurology, Dong-A University Medical Center, Busan, Korea, 2.Peripheral Neuropathy Research Center, Dong-A University College of Medicine, Busan, Korea, 3.Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea)

There are regional variations in the clinical features of Guillain-Barré syndrome (GBS). Acute motor axonal neuropathy (AMAN) and Miller Fisher syndrome are more frequently seen in the east Asia including Japan than in the western countries. In particular, AMAN type is reported to be far more frequent in Bangladesh than in the other regions. Expensive thrapies such as IVIg and plasmapheresis are not always available in the developing countries. In this symposium, clinical features and therapies of GBS in several Asian countries ( Korea, China and Bangladesh) will be reported. Such information should be useful for Japanese neurologists.

[EANF-01-2] Guillain-Barre syndrome in China

Liying Cui (Peking Union Medical College Hospital)

There are regional variations in the clinical features of Guillain-Barré syndrome (GBS). Acute motor axonal neuropathy (AMAN) and Miller Fisher syndrome are more frequently seen in the east Asia including Japan than in the western countries. In particular, AMAN type is reported to be far more frequent in Bangladesh than in the other regions. Expensive thrapies such as IVIg and plasmapheresis are not always available in the developing countries. In this symposium, clinical features and therapies of GBS in several Asian countries ( Korea, China and Bangladesh) will be reported. Such information should be useful for Japanese neurologists.

[EANF-01-3] Guillain-Barré syndrome in Bangladesh - An overview

Md Badrul Islam1,2, Zhahirul Islam1, Hubert P. Endtz1,2,3, Quazi D. Mohammad4, Bart Jacobs5 (1.The International Centre for Diarrhoeal Disease Research, (icddr,b), Bangladesh, 2.Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, The Netherlands, 3.Fondation Mérieux, France, 4.National Institute of Neurosciences and Hospital, Bangladesh, 5.Departments of Neurology and Immunology, Erasmus University Medical Centre, The Netherlands)

There are regional variations in the clinical features of Guillain-Barré syndrome (GBS). Acute motor axonal neuropathy (AMAN) and Miller Fisher syndrome are more frequently seen in the east Asia including Japan than in the western countries. In particular, AMAN type is reported to be far more frequent in Bangladesh than in the other regions. Expensive thrapies such as IVIg and plasmapheresis are not always available in the developing countries. In this symposium, clinical features and therapies of GBS in several Asian countries ( Korea, China and Bangladesh) will be reported. Such information should be useful for Japanese neurologists.